Average Co-Inventor Count = 3.36
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Wyeth (20 from 1,309 patents)
2. Genetics Institute, Inc. (16 from 389 patents)
3. Harvard College (3 from 2,963 patents)
4. Allied Corporation (2 from 1,393 patents)
5. Medimmune Limited (2 from 541 patents)
6. Other (1 from 832,843 patents)
7. Wisconsin Alumni Research Foundation (1 from 4,125 patents)
8. Johns Hopkins University (1 from 3,687 patents)
9. Cambridge Antibody Technology Limited (1 from 28 patents)
10. Genetics, Institute Institute, Llc. (1 from 1 patent)
11. Genetics Institute, LLC Et Al. (0 patent)
39 patents:
1. 9505831 - Isolated cell comprising a nucleic acid encoding antibody inhibitors of gdf-8 and uses thereof
2. 8940874 - Neutralizing antibodies against GDF-8 and uses therefor
3. 8710202 - Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
4. 8710025 - Modified and stabilized GDF propeptides and uses thereof
5. 8420082 - Neutralizing antibodies against GDF-8 and uses therefor
6. 8222384 - Modified and stabilized GDF propeptides and uses thereof
7. 8092798 - Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8
8. 7956038 - GASP1: a follistatin domain containing protein
9. 7737116 - Modified and stabilized GDF propeptides and uses thereof
10. 7731961 - Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
11. 7678885 - Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
12. 7655763 - Neutralizing antibodies against GDF-8 and uses therefor
13. 7585835 - GASP1: a follistatin domain containing protein
14. 7572763 - Follistatin domain containing proteins
15. 7572599 - Metalloprotease activation of myostatin, and methods of modulating myostatin activity